Stay updated on Entrectinib in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed specific references to three clinical trial analyses involving entrectinib and crizotinib, while retaining similar content from other studies on the same drug's effectiveness in treating ROS1+ NSCLC and NTRK fusion-positive solid tumors.
    Difference
    2%
    Check dated 2025-05-17T07:15:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-05-10T02:20:12.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-05-02T22:38:24.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1%
    Check dated 2025-04-25T21:02:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and inclusion/exclusion criteria for a clinical trial involving entrectinib, while adding a list of cancer types and a new revision number.
    Difference
    15%
    Check dated 2025-04-18T14:35:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The date '2025-03-17' has been added, while '2025-03-25' has been removed from the page.
    Difference
    1%
    Check dated 2025-04-11T10:52:51.000Z thumbnail image

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.